18 Background 19 Cutaneous (CL) and mucocutaneous (MCL) leishmaniasis remain as endemic tropical 20 diseases in several Latin American countries. This study aimed to estimate the burden of CL 21 and MCL in Ecuador for the period 2014-2018, in order to inform decision-making and resource 22 allocation to tackle this neglected disease. 23 Methods 24 Ambulatory consultations, hospitalizations, and reported cases of Leishmaniasis 25 registered by the Ecuadorian National Institute of Statistics and Census and the Ministry of 26 Public Health were used to estimate the burden of CL and MCL during a five-year period. Case 27 estimations were stratified by prevalence of acute and long-term sequelae, to calculate Years 28 Lived with Disability (YLD) by sex and age group using the DALY package in R. Spatial 29 analysis was conducted to identify statistically significant spatial clusters of leishmaniasis. 30 Results 31 Between years 2014 and 2018, a total 6,937 cases of leishmaniasis were registered, with 32 an average of 1,395 cases reported per year, 97.5% of them were CL and 2.5% MCL. The 33 average cumulative incidence for the study period corrected for underreporting was estimated in 34 21.98 to 36.10 per 100 thousand inhabitants. Health losses due to leishmaniasis reach 0.32 35 DALY per 100,000 people per year (95% CI 0.15 -0.49). The most affected by the disease 36 were men between 15 to 64 years old living below 1,500 m.a.s.l. in sub-tropical and tropical 37 rural communities on both slopes of the Andes mountains. Cantons with the highest cumulative 38 incidence of CL and MCL were Pedro Vicente Maldonado, San Miguel de Los Bancos, and 39 Puerto Quito, in the Pichincha Province; Taisha and Aguarico in the Morona Santiago and 40 Orellana provinces respectively. 3 41 Conclusion 42 Compared to previous reports, in the past five years CL and MCL persist as a public 43 health problem in Ecuador. There is a need for more comprehensive and robust data sources to 44 track leishmania cases in Ecuador. 45
Introduction 58
The leishmaniases are a group of zoonoses caused by the protozoa of the genus 59 Leishmania, which is transmitted by the bite of an infected female sand fly. Around 20 60
Leishmania species are implicated in human disease, producing several clinical presentations 61 from cutaneous (CL) to the destructive mucosal (ML), mucocutaneous (MCL), and a visceral 62 (VL) known as kala-azar, which is often fatal if left untreated [1, 2] .
63
The republic of Ecuador is a country located in South America, crossed transversally by 64 the Equator line and longitudinally (north to south) by the Andes belt mountains, dividing the country in four natural regions. Each region has different ecosystems, but also attitudes, believes and life style of the people. These ecosystems include richest in flora and fauna for 67 transmission of vector-borne parasitic diseases including Leishmania at each region. Leishmania 68 vectors and reservoirs showed a broad distribution across all the biomes of Ecuador, with . cutaneous and mucocutaneous leishmaniasis in Ecuador, and the first to analyze for possible spatial clusters at country level. Furthermore, the present study updates previous 215 epidemiological reports about the epidemiology of leishmaniases in Ecuador [5, 11, 31] . 
254
The Amazon region is vast and has a low population density when compared to the rest of the 255 country, for these reasons, local surveillance should be applied for leishmaniasis cases and more 256 studies are required regarding the transmission of leishmaniasis. The coastal clusters of 257 leishmaniasis show that there is an uneven distribution in these lowlands, it is necessary to study 258 the cause of these differences in the search of a possible explanation for protective/risk factors 259 associated with leishmaniasis cases.
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